Eli Lilly is the world’s most valuable drug company, partially known for blockbuster anti-obesity drugs that are transforming America. In an episode of “The David Rubenstein Show: Peer to Peer Conversations,” CEO Dave Ricks talks about how GLP-1 anti-obesity medications work and Lilly’s plans to develop a pill. Ricks also discusses the side effects that come from taking these drugs. This interview was recorded on December 10 at the Economic Club of Washington DC. (Source: Bloomberg)
Another blast of winter weather is wreaking havoc on air travel. Two busy hubs in Texas have already been hit with disruptions, and they could [more…]
New day, new Nintendo Switch 2 leaks. Nintendo is getting ever-closer to its April 2025 deadline to reveal its Switch successor, but thanks new renders [more…]
Sonic Labs has announced that the Ethereum virtual machine layer-1 chain Sonic now supports the bridged version of Circle stablecoin USDC. The USDC.e stablecoin on [more…]
[matched_con] Source link
GB News presenter Martin Daubney has challenged Liberal Democrat MP Steff Aquarone over his party’s decision to abstain from Wednesday’s vote on launching a national [more…]
Tom Brady is set to leave his £300m Fox Sports analyst role to work full-time in the Las Vegas Raiders front office next season, according [more…]
Watch the moment a drunk driver who was nearly four times over the legal limit, drove into oncoming traffic on a busy A road after [more…]
TL;DR Analysts project XRP could hit new highs, with forecasts ranging from $4 to $9. However, one market observer envisioned a double-digit crash if the [more…]
+ There are no comments
Add yours